Avisi Technologies, Inc., an ophthalmic medical device company advancing novel, sight-saving technologies, announces the first patient in the international SAPPHIRE Trial has been treated with Avisi's ...

Steadfast religious conviction on gay marriage and transgender ideology means the 83-year-old has been disowned by Australia ...

Asia Pathogen Genomics Initiative (Asia PGI) today offered the first public preview of PathGen, an AI-powered sense-making and decision-making support platform of pathogen genomics and contextual data ...

The use of IL-1 alpha and beta inhibition with ARCALYST has increasingly become the preferred treatment for recurrent ...